New Zealand markets open in 8 hours 16 minutes

Cytogen, Inc. (217330.KQ)

KOSDAQ - KOSDAQ Delayed price. Currency in KRW
Add to watchlist
8,450.00-150.00 (-1.74%)
At close: 03:30PM KST
Currency in KRW

Valuation measures4

Market cap (intra-day) 192.32B
Enterprise value 150.30B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)58.84
Price/book (mrq)3.37
Enterprise value/revenue 45.98
Enterprise value/EBITDA -29.72

Trading information

Stock price history

Beta (5Y monthly) 0.54
52-week change 3-50.49%
S&P500 52-week change 324.96%
52-week high 319,330.00
52-week low 37,870.00
50-day moving average 310,758.00
200-day moving average 313,297.30

Share statistics

Avg vol (3-month) 384.32k
Avg vol (10-day) 368.64k
Shares outstanding 522.36M
Implied shares outstanding 622.52M
Float 810.29M
% held by insiders 153.44%
% held by institutions 10.03%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 328 Sept 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-422.40%

Management effectiveness

Return on assets (ttm)-12.64%
Return on equity (ttm)-49.15%

Income statement

Revenue (ttm)3.27B
Revenue per share (ttm)168.43
Quarterly revenue growth (yoy)11.90%
Gross profit (ttm)N/A
EBITDA -9.96B
Net income avi to common (ttm)-14.77B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)55.84B
Total cash per share (mrq)2,508.13
Total debt (mrq)13.82B
Total debt/equity (mrq)24.20%
Current ratio (mrq)18.32
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-8.24B
Levered free cash flow (ttm)-13.84B